Items where Research Centre is "College of Medical Veterinary and Life Sciences > School of Infection & Immunity > Centre for Immunobiology" and Year is 2022

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Authors | Item Type | No Grouping
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y
Number of items: 144.


Aletaha, D. et al. (2022) Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Annals of the Rheumatic Diseases, (doi: 10.1136/ard-2022-222784) (PMID:35953263) (Early Online Publication)

Alivernini, S., Firestein, G. S. and McInnes, I. B. (2022) The pathogenesis of rheumatoid arthritis. Immunity, 55(12), pp. 2255-2270. (doi: 10.1016/j.immuni.2022.11.009) (PMID:36516818)

Alunno, A. et al. (2022) 2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19. Annals of the Rheumatic Diseases, 81(1), pp. 34-40. (doi: 10.1136/annrheumdis-2021-221366) (PMID:34620584) (PMCID:PMC8507408)

Audshasai, T. et al. (2022) Streptococcus pneumoniae rapidly translocate from the nasopharynx through the cribriform plate to invade the outer meninges. mBio, 13(4), e0102422. (doi: 10.1128/mbio.01024-22) (PMID:35924840)


Bachmair, E.-M. et al. (2022) Remotely delivered cognitive behavioural and personalised exercise interventions for fatigue severity and impact in inflammatory rheumatic diseases (LIFT): a multicentre, randomised, controlled, open-label, parallel-group trial. Lancet Rheumatology, 4(8), e534-e545. (doi: 10.1016/S2665-9913(22)00156-4)

Bain, C. C., Louwe, P. A., Steers, N. J., Bravo-Blas, A., Hegarty, L. M., Pridans, C., Milling, S. W.F. , MacDonald, A. S., Rückerl, D. and Jenkins, S. J. (2022) CD11c identifies microbiota and EGR2‐dependent MHCII + serous cavity macrophages with sexually dimorphic fate in mice. European Journal of Immunology, 52(8), pp. 1243-1257. (doi: 10.1002/eji.202149756) (PMID:35568024) (PMCID:PMC7613339)

Bain, K. A., Nichols, B., Kerbiriou, C., Moffat, F., Ijaz, U. Z. , Gerasimidis, K. , McInnes, I. B. , Åstrand, A., Holmes, S. and Milling, S. W. F. (2022) Stratification of alopecia areata reveals involvement of CD4 T cell populations and altered faecal microbiota. Clinical and Experimental Immunology, 210(2), pp. 175-186. (doi: 10.1093/cei/uxac088) (PMID:36200950) (PMCID:PMC9750826)

Baldacchino, K. et al. (2022) Myelinated axons are the primary target of hemin-mediated oxidative damage in a model of the central nervous system. Experimental Neurology, 354, 114113. (doi: 10.1016/j.expneurol.2022.114113) (PMID:35569511)

Bartolini, R. , Medina-Ruiz, L., Hayes, A. J., Kelly, C. J., Halawa, H. A. and Graham, G. J. (2022) Inflammatory chemokine receptors support inflammatory macrophage and dendritic cell maturation. ImmunoHorizons, 6(11), pp. 743-759. (doi: 10.4049/immunohorizons.2200069) (PMID:36426967)

Bejad, M., Bonilha, C. S., McInnes, I. B. , Garside, P. and Benson, R. A. (2022) Tofacitinib inhibits CD4 T cell polarisation to Th1 during priming thereby leading to clinical impact in a model of experimental arthritis. Clinical and Experimental Rheumatology, 40(7), pp. 1313-1323. (doi: 10.55563/clinexprheumatol/4rqeg0) (PMID:34494958)

Bennett, S. E., Almeida, C., Bachmair, E.-M., Gray, S. R. , Lovell, K., Paul, L., Wearden, A., Macfarlane, G. J., Basu, N. and Dures, E. (2022) Remotely delivered cognitive-behavioural and personalised exercise interventions to lessen the impact of fatigue: a qualitative evaluation. Rheumatology Advances in Practice, 6(2), rkac051. (doi: 10.1093/rap/rkac051) (PMID:35795008)

Bennett, S. E., Almeida, C., Bachmair, E.-M., Gray, S. R. , Lovell, K., Paul, L., Wearden, A., Macfarlane, G. J., Basu, N. and Dures, E. (2022) Therapists’ experiences of remotely delivering cognitive-behavioural or graded-exercise interventions for fatigue: a qualitative evaluation. Rheumatology Advances in Practice, 6(3), rkac083. (doi: 10.1093/rap/rkac083) (PMID:36340509) (PMCID:PMC9629972)

Bianchi, E., Najm, A. , Vanbelle, S., Le Goff, B., Mutijima, E., Kaiser, M.-J., Malaise, M. and Hauzeur, J.-P. (2022) Impact of the biopsy forceps size on histological analysis and performances of the histological scoring systems. Scientific Reports, 12, 5692. (doi: 10.1038/s41598-022-09704-w) (PMID:35383240)

Bodmer, M., Itano, A. and McInnes, I. (2022) Harnessing the small intestinal axis to resolve systemic inflammation. Frontiers in Immunology, 13, 1060607. (doi: 10.3389/fimmu.2022.1060607) (PMID:36458009) (PMCID:PMC9706197)

Bonneuil, W., Watson, D., Frattolin, J., Russell, M. J., Fasanella Masci, F., Bandara, M. , Brook, B. S., Nibbs, R. J.B. and Moore, J. (2022) Generation of stable advective-diffusive chemokine gradients in a three-dimensional hydrogel. AIP Advances, 12(2), 025121. (doi: 10.1063/5.0064947)

Burgoyne, P., Hayes, A. J., Cooper, R. S., Le Brocq, M. L., Hansell, C. A.H., Campbell, J. D.M. and Graham, G. J. (2022) CCR7+ dendritic cells sorted by binding of CCL19 show enhanced Ag-presenting capacity and antitumor potency. Journal of Leukocyte Biology, 111(6), pp. 1243-1251. (doi: 10.1002/JLB.5AB0720-446RR) (PMID:34780080)


Caiazzo, E., Rezig, A. O.M. , Bruzzese, D., Ialenti, A., Cicala, C., Cleland, J. G.F. , Guzik, T. J., Maffia, P. and Pellicori, P. (2022) Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: a systematic review and meta-analysis of randomised trials. Pharmacological Research, 176, 106053. (doi: 10.1016/j.phrs.2021.106053) (PMID:34979235) (PMCID:PMC8719379)

Camargo da Rosa, L. , Scales, H. E. , Makhija, S., Sutherland, K., Benson, R. A. , Brewer, J. M. and Garside, P. (2022) Revealing stromal and lymphoid sources of Col3a1-expression during inflammation using a novel reporter mouse. Discovery Immunology, 1(1), kyac008. (doi: 10.1093/discim/kyac008)

Campbell, C. I., McGonigal, R. , Barrie, J. A., Delaere, J., Bracke, L., Cunningham, M. E. , Yao, D., Delahaye, T., Van de Walle, I. and Willison, H. J. (2022) Complement inhibition prevents glial nodal membrane injury in a GM1 antibody-mediated mouse model. Brain Communications, 4(6), fcac306. (doi: 10.1093/braincomms/fcac306) (PMID:36523267) (PMCID:PMC9746686)

Canning, J., Siebert, S. , Jani, B. , Harding-Edgar, L., Kempe, I., Mair, F. S. and Nicholl, B. I. (2022) Examining the relationship between rheumatoid arthritis, multimorbidity and adverse health-related outcomes: a systematic review. Arthritis Care and Research, 74(9), pp. 1500-1512. (doi: 10.1002/acr.24587) (PMID:33650196)

Challoumas, D., Murray, E., Ng, N., Putti, A. and Millar, N. (2022) A meta-analysis of surgical interventions for base of thumb arthritis. Journal of Wrist Surgery, 11(6), pp. 550-560. (doi: 10.1055/s-0042-1743117) (PMID:36504527) (PMCID:PMC9731743)

Chauché, C. , Rasid, O., Donachie, A. M., McManus, C. M., Löser, S., Campion, T., Richards, J., Smyth, D. J. , McSorley, H. J. and Maizels, R. M. (2022) Suppression of airway allergic eosinophilia by Hp-TGM, a helminth mimic of TGF-β. Immunology, 167(2), pp. 197-211. (doi: 10.1111/imm.13528) (PMID:35758054) (PMCID:PMC9885513)

Coates, L. C., Gossec, L., Theander, E., Bergmans, P., Neuhold, M., Karyekar, C. S., Shawi, M., Noël, W., Schett, G. and McInnes, I. B. (2022) Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS). Annals of the Rheumatic Diseases, 81(3), pp. 359-369. (doi: 10.1136/annrheumdis-2021-220991) (PMID:34819273)

Coates, L. C. et al. (2022) Safety and efficacy of bimekizumab in patients with active psoriatic arthritis: 3-year results from a phase 2b randomized controlled trial and its open-label extension study. Arthritis and Rheumatology, 74(12), pp. 1959-1970. (doi: 10.1002/art.42280) (PMID:35829656)

Colaço, K. et al. (2022) Association of cardiac biomarkers with cardiovascular outcomes in patients with psoriatic arthritis and psoriasis: a longitudinal cohort study. Arthritis and Rheumatology, 74(7), pp. 1184-1192. (doi: 10.1002/art.42079) (PMID:35261189)

Crawford, C. L. et al. (2022) SARM1 depletion slows axon degeneration in a CNS model of neurotropic viral infection. Frontiers in Molecular Neuroscience, 15, 860410. (doi: 10.3389/fnmol.2022.860410) (PMID:35493328) (PMCID:PMC9043327)

Cunningham, M. E. , McGonigal, R. , Barrie, J. A., Yao, D. and Willison, H. J. (2022) Real time imaging of intra-axonal calcium flux in an explant mouse model of axonal Guillain-Barré syndrome. Experimental Neurology, 355, 114127. (doi: 10.1016/j.expneurol.2022.114127) (PMID:35640716) (PMCID:PMC7614209)

Curio, S. et al. (2022) NKG2D signaling regulates IL-17A-producing γδT cells in mice to promote cancer progression. Discovery Immunology, 1(1), kyac002. (doi: 10.1093/discim/kyac002) (PMID:36277678) (PMCID:PMC9580227)

Curtis, J. R. et al. (2022) The effect of guselkumab on work productivity in biologic-naïve patients with active psoriatic arthritis through week 52 of the phase 3, randomized, placebo-controlled DISCOVER-2 trial. Advances in Therapy, 39(10), pp. 4613-4631. (doi: 10.1007/s12325-022-02270-7) (PMID:35947349)

Curtis, J. R. et al. (2022) The effect of guselkumab on general health state in biologic-naïve patients with active psoriatic arthritis through week 52 of the phase 3, randomized, placebo-controlled DISCOVER-2 trial. Advances in Therapy, 39(10), pp. 4632-4644. (doi: 10.1007/s12325-022-02269-0) (PMID:35947348)


de Thurah, A. et al. (2022) 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases. Annals of the Rheumatic Diseases, 81(8), pp. 1065-1071. (doi: 10.1136/annrheumdis-2022-222341) (PMID:35470160)

Degboe, Y., Sunzini, F., Sood, S., Bozec, A., Sokolova, M. V., Zekovic, A., McInnes, I. B. , Schett, G. and Goodyear, C. S. (2022) Apremilast inhibits inflammatory osteoclastogenesis. Rheumatology, 61(1), pp. 452-461. (doi: 10.1093/rheumatology/keab315) (PMID:33788924)

Degboe, Y., Vastert, S. J., Prakken, B. J. and McInnes, I. B. (2022) How does age determine the development of human immune-mediated arthritis? Nature Reviews Rheumatology, 18(9), pp. 501-512. (doi: 10.1038/s41584-022-00814-3) (PMID:35948692) (PMCID:PMC9363867)

Docherty, S., Harley, R., McAuley, J. J., Crowe, L. A.N., Padret, C., Kirwan, P. D., Siebert, S. and Millar, N. L. (2022) The effect of exercise on cytokines: implications for musculoskeletal health: a narrative review. BMC Sports Science, Medicine and Rehabilitation, 14(1), 5. (doi: 10.1186/s13102-022-00397-2) (PMID:34991697) (PMCID:PMC8740100)

Drurey, C. et al. (2022) Intestinal epithelial tuft cell induction is negated by a murine helminth and its secreted products. Journal of Experimental Medicine, 219(1), e20211140. (doi: 10.1084/jem.20211140) (PMID:34779829) (PMCID:PMC8597987)


Edgar, N., Clifford, C., O’Neill, S., Pedret, C., Kirwan, P. D. and Millar, N. L. (2022) A biopsychosocial approach to tendinopathy. BMJ Open Sport and Exercise Medicine, 8, e001326. (doi: 10.1136/bmjsem-2022-001326) (PMID:35990762) (PMCID:PMC9345071)


Farina, L. et al. (2022) Pro nerve growth factor and its receptor p75NTR activate inflammatory responses in synovial fibroblasts: a novel targetable mechanism in arthritis. Frontiers in Immunology, 13, 818630. (doi: 10.3389/fimmu.2022.818630) (PMID:35309353) (PMCID:PMC8931659)

Ferguson, L. D. et al. (2022) Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease – results of the Immune Metabolic Associations in Psoriatic Arthritis study. Rheumatology, 61(3), pp. 1026-1034. (doi: 10.1093/rheumatology/keab474) (PMID:34097014) (PMCID:PMC8889283)

Fodor, D. et al. (2022) The EFSUMB guidelines and recommendations for musculoskeletal ultrasound – Part I: Extraarticular pathologies. Ultraschall in der Medizin, 43(1), pp. 34-57. (doi: 10.1055/a-1562-1455) (PMID:34479372)

Forster, S. C. et al. (2022) Identification of gut microbial species linked with disease variability in a widely used mouse model of colitis. Nature Microbiology, 7(4), pp. 590-599. (doi: 10.1038/s41564-022-01094-z) (PMID:35365791) (PMCID:PMC8975739)

Fragoulis, G. E., Nikiphorou, E., McInnes, I. B. and Siebert, S. (2022) Does age matter in psoriatic arthritis? A narrative review. Journal of Rheumatology, 49(10), pp. 1085-1091. (doi: 10.3899/jrheum.210349) (PMID:34393099)

Fragoulis, G. E. and Siebert, S. (2022) The role of IL-23 and the use IL-23 inhibitors in psoriatic arthritis. Musculoskeletal Care, 20(S1), S12-S21. (doi: 10.1002/msc.1694) (PMID:36069174)


Goebel, A. et al. (2022) Research recommendations following the discovery of pain sensitising IgG autoantibodies in fibromyalgia syndrome. Pain Medicine, 23(6), pp. 1084-1094. (doi: 10.1093/pm/pnab338) (PMID:34850195) (PMCID:PMC9157149)

Goñi, M., Basu, N. , Murray, A. D. and Waiter, G. D. (2022) Brain predictors of fatigue in Rheumatoid Arthritis: a machine learning study. PLoS ONE, 17(6), e0269952. (doi: 10.1371/journal.pone.0269952) (PMID:35759489) (PMCID:PMC9236264)

Gossec, L. et al. (2022) Persistence and effectiveness of the IL-12/23 pathway inhibitor ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: 1-year results from the real-world PsABio Study. Annals of the Rheumatic Diseases, 81, pp. 823-830. (doi: 10.1136/annrheumdis-2021-221640) (PMID:35210262)

Gottlieb, A. B. et al. (2022) Long-term safety of secukinumab over five years in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis and ankylosing spondylitis: update on integrated pooled clinical trial and post-marketing surveillance data. Acta Dermato Venereologica, 102, adv00698. (doi: 10.2340/actadv.v102.563) (PMID:35146532)

Gurke, R. et al. (2022) Omics and multi-omics analysis for the early identification and improved outcome of patients with psoriatic arthritis. Biomedicines, 10(10), 2387. (doi: 10.3390/biomedicines10102387) (PMID:36289648)


Halstead, S.K. et al. (2022) Serum anti-GM2 and anti-GalNAc-GD1a IgG antibodies are biomarkers for acute canine polyradiculoneuritis. Journal of Small Animal Practice, 63(2), pp. 104-112. (doi: 10.1111/jsap.13439) (PMID:34791652)

Halstead, S. K., Gourlay, D. and Willison, H. J. (2022) Detection of autoantibodies using combinatorial glycolipid microarrays. In: Kilcoyne, M. and Gerlach, J. Q. (eds.) Glycan Microarrays: Methods and Protocols. Series: Methods in Molecular Biology, 2460. Humana Press: New York, pp. 183-191. ISBN 9781071621479 (doi: 10.1007/978-1-0716-2148-6_11)

Hanlon, P. , Morrison, H., Morton, F. , Jani, B. D. , Siebert, S. , Lewsey, J. , McAllister, D. and Mair, F. S. (2022) Frailty in people with rheumatoid arthritis: a systematic review of observational studies. Wellcome Open Research, 6, 244. (doi: 10.12688/wellcomeopenres.17208.2)

Hanlon, P. , Morton, F. , Siebert, S. , Jani, B. D. , Nicholl, B. I. , Lewsey, J. , McAllister, D. and Mair, F. S. (2022) Frailty in rheumatoid arthritis and its relationship with disease activity, hospitalisation and mortality: a longitudinal analysis of the Scottish Early Rheumatoid Arthritis cohort and UK Biobank. RMD Open, 8(1), e002111. (doi: 10.1136/rmdopen-2021-002111) (PMID:35292529) (PMCID:PMC8928366)

Hargrave, K. E., MacLeod, M. K.L. and Worrell, J. C. (2022) Antigen presenting cells: professionals, amateurs, and spectators in the 'long game' of lung immunity. International Journal of Biochemistry and Cell Biology, 153, 106331. (doi: 10.1016/j.biocel.2022.106331) (PMID:36368596)

Harnett, M. M. et al. (2022) The parasitic worm product ES-62 protects the osteoimmunology axis in a mouse model of obesity-accelerated ageing. Frontiers in Immunology, 13, 953053. (doi: 10.3389/fimmu.2022.953053) (PMID:36105811) (PMCID:PMC9465317)

Hendry, G. J. et al. (2022) Gait rehabilitation for foot and ankle impairments in early rheumatoid arthritis: a feasibility study of a new gait rehabilitation programme (GREAT Strides). Pilot and Feasibility Studies, 8, 115. (doi: 10.1186/s40814-022-01061-9)

Hentzschel, F., Gibbins, M. P. , Attipa, C., Beraldi, D., Moxon, C. A. , Otto, T. D. and Marti, M. (2022) Host cell maturation modulates parasite invasion and sexual differentiation in Plasmodium berghei. Science Advances, 8(17), eabm7348. (doi: 10.1126/sciadv.abm7348) (PMID:35476438) (PMCID:PMC9045723)

Hsieh, P. H., Geue, C. , Wu, O. , McIntosh, E. and Siebert, S. (2022) How do multiple long-term conditions impact on the cost-of-illness in early rheumatoid arthritis? RMD Open, 8, e002454. (doi: 10.1136/rmdopen-2022-002454) (PMID:36104116) (PMCID:PMC9476122)

Huesa, C. et al. (2022) Moderate exercise protects against joint disease in a murine model of osteoarthritis. Frontiers in Physiology, 13, 1065278. (doi: 10.3389/fphys.2022.1065278) (PMID:36545287) (PMCID:PMC9760924)

Hulme, H. et al. (2022) Mapping the influence of the gut microbiota on small molecules across the microbiome gut brain axis. Journal of the American Society for Mass Spectrometry, 33(4), pp. 649-659. (doi: 10.1021/jasms.1c00298) (PMID:35262356) (PMCID:PMC9047441)


Iaconelli, A., Pellicori, P. , Caiazzo, E., Rezig, A. O. M. , Bruzzese, D., Maffia, P. and Cleland, J. G. F. (2022) Implanted haemodynamic telemonitoring devices to guide management of heart failure: a review and meta-analysis of randomised trials. Clinical Research in Cardiology, (doi: 10.1007/s00392-022-02104-0) (PMID:36241896) (PMCID:PMC9568893) (Early Online Publication)


Jackson, M. R. et al. (2022) Low-dose lung radiotherapy for COVID-19 lung disease: a preclinical efficacy study in a bleomycin model of pneumonitis. International Journal of Radiation Oncology, Biology, Physics, 112(1), pp. 197-211. (doi: 10.1016/j.ijrobp.2021.08.029) (PMID:34478832) (PMCID:PMC8406661)


Kastrati, K. et al. (2022) A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases. RMD Open, 8(2), e002359. (doi: 10.1136/rmdopen-2022-002359) (PMCID:PMC9462104)

Kelly, L., McGrath, S., Rodgers, L., McCall, K., Tulunay Virlan, A. , Dempsey, F., Crichton, S. and Goodyear, C. S. (2022) Annexin-A1: the culprit or the solution? Immunology, 166(1), pp. 2-16. (doi: 10.1111/imm.13455) (PMID:35146757)

Kolbinger, F. et al. (2022) Secukinumab for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis: physical and pharmacological properties underlie the observed clinical efficacy and safety. Pharmacology and Therapeutics, 229, 107925. (doi: 10.1016/j.pharmthera.2021.107925) (PMID:34171337)

Kroon, F. P.B., Najm, A. , Alunno, A., Schoones, J. W., Landewé, R. B.M., Machado, P. M. and Navarro-Compán, V. (2022) Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations. Annals of the Rheumatic Diseases, 81(3), pp. 422-432. (doi: 10.1136/annrheumdis-2021-221575) (PMID:34876462)

Krueger, J. G., McInnes, I. B. and Blauvelt, A. (2022) Tyrosine kinase 2 and Janus kinase‒signal transducer and activator of transcription signaling and inhibition in plaque psoriasis. Journal of the American Academy of Dermatology, 86(1), pp. 148-157. (doi: 10.1016/j.jaad.2021.06.869) (PMID:34224773)

Kwon, J., Arsenis, C., Suessmilch, M., McColl, A., Cavanagh, J. and Morris, B. J. (2022) Differential effects of toll-like receptor activation and differential mediation by MAP kinases of immune responses in microglial cells. Cellular and Molecular Neurobiology, 42(8), pp. 2655-2671. (doi: 10.1007/s10571-021-01127-x) (PMID:34297254) (PMCID:PMC9560989)


Landewé, R. B.M. et al. (2022) EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update. Annals of the Rheumatic Diseases, 81(12), pp. 1629-1639. (doi: 10.1136/annrheumdis-2021-222006) (PMID:35197264)

Lawrence, M., Wiesheu, R. and Coffelt, S. B. (2022) The duplexity of unconventional T cells in cancer. International Journal of Biochemistry and Cell Biology, 146, 106213. (doi: 10.1016/j.biocel.2022.106213) (PMID:35447350)

Lee, R., Leighton, S. P. , Thomas, L., Gkoutos, G. V., Wood, S. J., Fenton, S.-J. H., Deligianni, F. , Cavanagh, J. and Mallikarjun, P. K. (2022) Prediction models in first-episode psychosis: systematic review and critical appraisal. British Journal of Psychiatry, 220(SI4), pp. 179-191. (doi: 10.1192/bjp.2021.219) (PMID:35067242)

Leighton, S. P. , Herron, J. W. , Jackson, E., Sheridan, M., Deligianni, F. and Cavanagh, J. (2022) Delirium and the risk of developing dementia: a cohort study of 12 949 patients. Journal of Neurology, Neurosurgery and Psychiatry, 93(8), pp. 822-827. (doi: 10.1136/jnnp-2022-328903) (PMID:35606105) (PMCID:PMC9304115)

Leonhard, S. E. et al. (2022) An international perspective on preceding infections in Guillain-Barré syndrome: The IGOS-1000 cohort. Neurology, 99(12), e1299-e1313. (doi: 10.1212/WNL.0000000000200885) (PMID:35981895)

Leslie, J. et al. (2022) CXCR2 inhibition enables NASH-HCC immunotherapy. Gut, 71(10), pp. 2093-2106. (doi: 10.1136/gutjnl-2021-326259) (PMID:35477863) (PMCID:PMC9484388)

Lindholm, H. T., Parmar, N., Drurey, C. , Campillo Poveda, M. , Vornewald, P. M., Ostrop, J., Díez-Sanchez, A., Maizels, R. M. and Oudhoff, M. J. (2022) BMP signaling in the intestinal epithelium drives a critical feedback loop to restrain IL-13–driven tuft cell hyperplasia. Science Immunology, 7(71), eabl6543. (doi: 10.1126/sciimmunol.abl6543) (PMID:35559665) (PMCID:PMC7614132)

Lindsay, S. L. , Molęda, A. M., MacLellan, L. M., Keh, S. M., McElroy, D. E., Linington, C. , Goodyear, C. S. and Barnett, S. C. (2022) Human olfactory mesenchymal stromal cell transplantation ameliorates experimental autoimmune encephalomyelitis revealing an inhibitory role for IL16 on myelination. Acta Neuropathologica Communications, 10, 12. (doi: 10.1186/s40478-022-01316-9) (PMID:35093166) (PMCID:PMC8800340)


Machado, P. M. et al. (2022) Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry. Annals of the Rheumatic Diseases, 81(5), pp. 695-709. (doi: 10.1136/annrheumdis-2021-221490) (PMID:34972811) (PMCID:PMC8720639)

MacKenzie, G., Jensen, R. W., Lavstsen, T. and Otto, T. D. (2022) Varia: a tool for prediction, analysis and visualisation of variable genes. BMC Bioinformatics, 23, 52. (doi: 10.1186/s12859-022-04573-6) (PMID:35073845) (PMCID:PMC8785495)

Maizels, R. M. (2022) Ascarosides from helminths pack a punch against allergy. Proceedings of the National Academy of Sciences of the United States of America, 119(14), e2202250119. (doi: 10.1073/pnas.2202250119) (PMID:35353624) (PMCID:PMC9169083)

McGonigal, R. , Campbell, C. I., Barrie, J. A., Yao, D., Cunningham, M. E. , Crawford, C. L., Rinaldi, S., Rowan, E. G. and Willison, H. J. (2022) Schwann cell nodal membrane disruption triggers bystander axonal degeneration in a Guillain-Barré syndrome mouse model. Journal of Clinical Investigation, 132(14), e158524. (doi: 10.1172/JCI158524) (PMID:35671105) (PMCID:PMC9282931)

McGonigal, R. and Willison, H. J. (2022) The role of gangliosides in the organisation of the node of Ranvier examined in glycosyltransferase transgenic mice. Journal of Anatomy, 241(5), pp. 1259-1271. (doi: 10.1111/joa.13562) (PMID:34605014) (PMCID:PMC9558150)

McInnes, I. B. , Iagnocco, A., Aletaha, D., Baraliakos, X., Bijlsma, J. W.J., Mateus, E. F., Szekanecz, Z., Vliet Vlieland, T. P.M. and Smolen, J. S. (2022) Reflections on a contemporary European tragedy. Annals of the Rheumatic Diseases, 81(6), pp. 747-748. (doi: 10.1136/annrheumdis-2022-222652) (PMID:35470159)

McInnes, I. B. et al. (2022) Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials. RMD Open, 8(1), e002049. (doi: 10.1136/rmdopen-2021-002049) (PMID:35332058)

McInnes, I. B. et al. (2022) Long‐term efficacy and safety of guselkumab, a monoclonal antibody specific to the p19 subunit of interleukin‐23, through 2 years: results from a phase 3, randomized, double‐blind, placebo‐controlled study conducted in biologic‐naïve patients with active psoriatic arthritis. Arthritis and Rheumatology, 74(3), pp. 475-485. (doi: 10.1002/art.42010) (PMID:34719872)

McInnes, I. B. , Sawyer, L. M., Markus, K., LeReun, C., Sabry-Grant, C. and Helliwell, P. S. (2022) Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes. RMD Open, 8(1), e002074. (doi: 10.1136/rmdopen-2021-002074) (PMID:35321874)

McInnes, I. B. et al. (2022) A review of JAK-STAT signalling in the pathogenesis of spondyloarthritis and the role of JAK inhibition. Rheumatology, 61(5), pp. 1783-1794. (doi: 10.1093/rheumatology/keab740) (PMID:34668515)

Mease, P. J. et al. (2022) Comparative effectiveness of guselkumab in psoriatic arthritis: updates to a systematic literature review and network meta-analysis. Rheumatology, (doi: 10.1093/rheumatology/keac500) (PMID:36102818) (Early Online Publication)

Medina-Ruiz, L. et al. (2022) Analysis of combinatorial chemokine receptor expression dynamics using multi-receptor reporter mice. eLife, 11, e72418. (doi: 10.7554/eLife.72418) (PMID:35699420) (PMCID:PMC9236609)

Meehan, G. R. , Scales, H. E. , McInnes, I. B. , Brewer, J. M. and Garside, P. (2022) Orally administered antigen can reduce or exacerbate pathology in an animal model of inflammatory arthritis dependent upon the timing of administration. Immunotherapy Advances, 2(1), ltac020. (doi: 10.1093/immadv/ltac020) (PMID:36268500) (PMCID:PMC9579813)

Merola, J. F., McInnes, I. B. , Deodhar, A. A., Dey, A. K., Adamstein, N. H., Quebe-Fehling, E., Aassi, M., Peine, M. and Mehta, N. N. (2022) Effect of secukinumab on traditional cardiovascular risk factors and inflammatory biomarkers: post hoc analyses of pooled data across three indications. Rheumatology and Therapy, 9(3), pp. 935-955. (doi: 10.1007/s40744-022-00434-z) (PMID:35305260) (PMCID:PMC9127026)

Micheroli, R. et al. (2022) Role of synovial fibroblast subsets across synovial pathotypes in rheumatoid arthritis: a deconvolution analysis. RMD Open, 8(1), e001949. (doi: 10.1136/rmdopen-2021-001949) (PMID:34987094) (PMCID:PMC8734041)

Millar, N. L. et al. (2022) Frozen shoulder. Nature Reviews Disease Primers, 8, 59. (doi: 10.1038/s41572-022-00386-2) (PMID:36075904)

Milling, S. (2022) Discovery Immunology, a new open access journal from the British Society for Immunology. Discovery Immunology, 1(1), kyab002. (doi: 10.1093/discim/kyab002)

Mirza, M. et al. (2022) Impact of the COVID‐19 pandemic on recruitment to clinical research studies in rheumatology. Musculoskeletal Care, 20(1), pp. 209-213. (doi: 10.1002/msc.1561) (PMID:33938621) (PMCID:PMC8242596)

Montoye, A. H.K., Vondrasek, J. D., Neph, S. E., Basu, N. , Paul, L., Bachmair, E.-M., Stefanov, K. and Gray, S. R. (2022) Comparison of the activPAL CREA and VANE algorithms for characterization of posture and activity in free-living adults. Journal for the Measurement of Physical Behaviour, 5(1), pp. 49-57. (doi: 10.1123/jmpb.2021-0053)

Morrow, A. et al. (2022) Prevention and early treatment of the long-term physical effects of COVID-19 in adults: design of a randomised controlled trial of resistance exercise—CISCO-21. Trials, 23, 660. (doi: 10.1186/s13063-022-06632-y) (PMID:35971155) (PMCID:PMC9376905)

Mortensen, J. H. et al. (2022) A specific calprotectin neo-epitope (CPa9-HNE) in serum from inflammatory bowel disease patients is associated with neutrophil activity and endoscopic severity. Journal of Crohn's and Colitis, 16(9), pp. 1447-1460. (doi: 10.1093/ecco-jcc/jjac047) (PMID:35304895) (PMCID:PMC9455793)

Mukundan, A., Byeon, C.-H., Hinck, C. S., Cunningham, K. , Campion, T., Smyth, D. J. , Maizels, R. M. and Hinck, A. P. (2022) Convergent evolution of a parasite-encoded complement control protein-scaffold to mimic binding of mammalian TGF-ß to its receptors, TßRI and TßRII. Journal of Biological Chemistry, 298(6), 101994. (doi: 10.1016/j.jbc.2022.101994) (PMID:35500648) (PMCID:PMC9163516)


Nagy, G. et al. (2022) EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis. Annals of the Rheumatic Diseases, 81(1), pp. 20-33. (doi: 10.1136/annrheumdis-2021-220973) (PMID:34407926) (PMCID:PMC8761998)

Najm, A. , Alunno, A., Gwinnutt, J. M., Weill, C. and Berenbaum, F. (2022) Efficacité des infiltrations intra-articulaires de corticoïdes dans la gonarthrose: revue systématique et méta-analyse d’essais comparatifs randomisés. Revue du Rhumatisme, 89(3), pp. 223-231. (doi: 10.1016/j.rhum.2021.10.561)

Najm, A. et al. (2022) EULAR Points to consider for minimal reporting requirements in synovial tissue research in rheumatology. Annals of the Rheumatic Diseases, 81(12), pp. 1640-1646. (doi: 10.1136/annrheumdis-2021-221875) (PMID:35210263)

Najm, A. , Costantino, F., Weill, C., Filer, A. and d’Agostino, M.-A. (2022) Impact of synovial biopsy procedures and disease-specific aspects on synovial tissue outcome: a systematic literature review informing the EULAR points to consider for the minimal reporting requirements in synovial tissue research in rheumatology. RMD Open, 8(1), e002116. (doi: 10.1136/rmdopen-2021-002116) (PMID:35177556) (PMCID:PMC8860072)

Naredo, E. et al. (2022) The EFSUMB guidelines and recommendations for musculoskeletal ultrasound – Part II: Joint pathologies, pediatric applications, and guided procedures. Ultraschall in der Medizin, 43(3), pp. 252-273. (doi: 10.1055/a-1640-9183) (PMID:34734404)

Naylor, G., Julian, L., Watson-Bryce, S., Mullin, M., Nibbs, R. J. and Olson, M. F. (2022) Immunogenic death of hepatocellular carcinoma cells in mice expressing caspase-resistant ROCK1 is not replicated by ROCK inhibitors. Cancers, 14(23), 5943. (doi: 10.3390/cancers14235943)

Ndondo, A. P., Eley, B., Wilmshurst, J. M., Kakooza-Mwesige, A., Giannoccaro, M. P., Willison, H. J. , Cruz, P. M. R., Heckmann, J. M., Bateman, K. and Vincent, A. (2022) Post-infectious autoimmunity in the central (CNS) and peripheral (PNS) nervous systems: an African perspective. Frontiers in Immunology, 13, 833548. (doi: 10.3389/fimmu.2022.833548)

Needham, E. J. et al. (2022) Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses. Brain, 145(11), pp. 4097-4107. (doi: 10.1093/brain/awac321) (PMID:36065116) (PMCID:PMC9494359)


Ogdie, A., Lindsay, C. A., Mease, P. J., Callis Duffin, K., Rosen, C. F. and Siebert, S. (2022) Challenges in the diagnosis and assessment of psoriatic arthritis. Journal of Rheumatology, 49(6 Sup1), pp. 64-67. (doi: 10.3899/jrheum.211337) (PMID:35428713)

Oguegbulu, J. C., Khalaf, A. I., Suckling, C. J., Harnett, M. M. and Harnett, W. (2022) Lead optimisation efforts on a molecular prototype of the immunomodulatory parasitic protein ES-62. Physical Sciences Reviews, (doi: 10.1515/psr-2021-0235)

Olsson, A. M. et al. (2022) miR-155 overexpressing monocytes resemble HLA highISG15 + synovial tissue macrophages from patients with rheumatoid arthritis and induce polyfunctional CD4+ T cell activation. Clinical and Experimental Immunology, 207(2), pp. 188-198. (doi: 10.1093/cei/uxab016) (PMID:35020867) (PMCID:PMC8982969)

Ovseiko, P. V. et al. (2022) Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task force. RMD Open, 8(2), e002518. (doi: 10.1136/rmdopen-2022-002518) (PMID:35940824)


Pancheva, A., Wheadon, H. , Rogers, S. and Otto, T. D. (2022) Using topic modeling to detect cellular crosstalk in scRNA-seq. PLoS Computational Biology, 18(4), e1009975. (doi: 10.1371/journal.pcbi.1009975) (PMID:35395014) (PMCID:PMC9064087)

Paterson, K., Paterson, S., Mulholland, T., Coffelt, S.B. and Zagnoni, M. (2022) Assessment of CAR-T mediated and targeted cytotoxicity in 3D microfluidic TBNC co-culture models for combination therapy. IEEE Open Journal of Engineering in Medicine and Biology, 3, pp. 86-95. (doi: 10.1109/OJEMB.2022.3178302)

Perona-Wright, G. and McSorley, H. J. (2022) Lessons from helminths: what worms have taught us about mucosal immunology. Mucosal Immunology, 15(6), pp. 1049-1051. (doi: 10.1038/s41385-022-00560-5) (PMID:35999461)

Prendergast, C. T., Benson, R. A. , Scales, H. E. , Bonilha, C. S., Cole, J. J., McInnes, I. , Brewer, J. M. and Garside, P. (2022) Dissecting the molecular control of immune cell accumulation in the inflamed joint. JCI Insight, 7(7), e151281. (doi: 10.1172/jci.insight.151281) (PMID:35192549)

Pugliese, N. R., Pellicori, P. , Filidei, F., De Biase, N., Maffia, P. , Guzik, T. J., Masi, S., Taddei, S. and Cleland, J. G.F. (2022) Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions. Cardiovascular Research, 118(18), pp. 3536-3555. (doi: 10.1093/cvr/cvac133) (PMID:36004819) (PMCID:PMC9897694)


Quintana, J. F. et al. (2022) Single cell and spatial transcriptomic analyses reveal microglia-plasma cell crosstalk in the brain during Trypanosoma brucei infection. Nature Communications, 13, 5752. (doi: 10.1038/s41467-022-33542-z) (PMID:36180478) (PMCID:PMC9525673)


Reuter, K., Haupt, C., Molto, A., Cope, A., van Vollenhoven, R. F., Elewaut, D., Lories, R. and McInnes, I. B. (2022) Levelling the playing field of RMD research across Europe to address patients’ needs: the emerging EULAR Research Centre. RMD Open, 8(2), e002456. (doi: 10.1136/rmdopen-2022-002456) (PMID:35714997) (PMCID:PMC9207999)

Ritchlin, C. T. et al. (2022) Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies. RMD Open, 8(1), e002195. (doi: 10.1136/rmdopen-2022-002195) (PMID:35296534)

Rutherford, M. A. and Basu, N. (2022) Reply to Riza and Hamit comment on ‘Factors influencing severe COVID‐19 in systemic vasculitis patients’. Arthritis and Rheumatology, 74(4), pp. 725-726. (doi: 10.1002/art.42024) (PMID:34783446) (PMCID:PMC8652784)


Samvelyan, H. J., Huesa, C., Cui, L., Farquharson, C. and Staines, K. A. (2022) The role of accelerated growth plate fusion in the absence of SOCS2 on osteoarthritis vulnerability. Bone and Joint Research, 11(3), pp. 162-170. (doi: 10.1302/2046-3758.113.bjr-2021-0259.r1) (PMID:35272487) (PMCID:PMC8962856)

Schett, G., Rahman, P., Ritchlin, C., McInnes, I. B. , Elewaut, D. and Scher, J. U. (2022) Psoriatic arthritis from a mechanistic perspective. Nature Reviews Rheumatology, 18(6), pp. 311-325. (doi: 10.1038/s41584-022-00776-6) (PMID:35513599)

Scott, J. et al. (2022) The association between ambient UVB dose and ANCA-associated vasculitis relapse and onset. Arthritis Research and Therapy, 24(1), 147. (doi: 10.1186/s13075-022-02834-6) (PMID:35717248)

Sherrard Smith, R., Barnett, S. C. and Lindsay, S. L. (2022) Generation of rat neural stem cells to produce different astrocyte phenotypes. In: Kannan, N. and Beer, P. (eds.) Stem Cell Assays: Methods and Protocols. Series: Methods in molecular biology (2429). Humana Press: New York, pp. 333-344. ISBN 9781071619780 (doi: 10.1007/978-1-0716-1979-7_21)

Stanciu, I., Anderson, J. , Siebert, S. , Mackay, D. and Lyall, D. M. (2022) Associations of mental health, sleep and cognition characteristics with rheumatoid arthritis and rheumatoid factor in the UK Biobank. Scientific Reports, 12, 19844. (doi: 10.1038/s41598-022-22021-6) (PMID:36400784)

Stober, C. et al. (2022) Proceedings of the 2021 GRAPPA-Collaborative Research Network (CRN) meeting. Journal of Rheumatology, 49(6 Sup1), pp. 57-63. (doi: 10.3899/jrheum.211336) (PMID:35365578)

Szczepaniak, P. et al. (2022) Breast cancer chemotherapy induces vascular dysfunction and hypertension through NOX4 dependent mechanism. Journal of Clinical Investigation, 132(13), e149117. (doi: 10.1172/JCI149117) (PMID:35617030) (PMCID:PMC9246378)


Tanaka, Y., Kavanaugh, A., Wicklund, J. and McInnes, I. B. (2022) Filgotinib, a novel JAK1-preferential inhibitor for the treatment of rheumatoid arthritis: an overview from clinical trials. Modern Rheumatology, 32(1), pp. 1-11. (doi: 10.1080/14397595.2021.1902617) (PMID:33740386)

Tank, R., Ward, J. , Flegal, K. E. , Smith, D. J. , Bailey, M. E.S. , Cavanagh, J. and Lyall, D. M. (2022) Association between polygenic risk for Alzheimer’s disease, brain structure and cognitive abilities in UK Biobank. Neuropsychopharmacology, 47(2), pp. 564-569. (doi: 10.1038/s41386-021-01190-4) (PMID:34621014) (PMCID:PMC8674313)

Thümmler, K. , Williams, M. T.S., Kitson, S., Sood, S., Akbar, M., Cole, J. J., Goodyear, C. S. , Hunter, E. and Soutar, R. (2022) Targeting 3D chromosomal architecture at the RANK loci to suppress myeloma-driven osteoclastogenesis. OncoImmunology, 11(1), 2104070. (doi: 10.1080/2162402X.2022.2104070) (PMID:35936985) (PMCID:PMC9348127)

Tucker, L. et al. (2022) The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs. Rheumatology, 61(9), e255-e266. (doi: 10.1093/rheumatology/keac295) (PMID:35640657)

Tucker, L. et al. (2022) Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs. Rheumatology, 61(9), pp. 2514-3520. (doi: 10.1093/rheumatology/keac260) (PMID:35640653)


van Gijsel-Bonnello, M. et al. (2022) Salt Inducible Kinase 2 regulates fibrosis during bleomycin-induced lung injury. Journal of Biological Chemistry, 298(12), 102644. (doi: 10.1016/j.jbc.2022.102644) (PMID:36309093)

van Wagensveld, L. et al. (2022) Homologous recombination deficiency and cyclin E1 amplification are correlated with immune cell infiltration and survival in high-grade serous ovarian cancer. Cancers, 14(23), 5965. (doi: 10.3390/cancers14235965)

Varyani, F. et al. (2022) The IL-25-dependent tuft cell circuit driven by intestinal helminths requires macrophage migration inhibitory factor (MIF). Mucosal Immunology, 15(6), pp. 1243-1256. (doi: 10.1038/s41385-022-00496-w) (PMID:35288645) (PMCID:PMC9705247)

Veale, D. J., Firestein, G. S., Wechalekar, M. D. and Najm, A. (2022) Editorial: Synovial tissue biopsy research. Frontiers in Medicine, 9, 1004029. (doi: 10.3389/fmed.2022.1004029) (PMID:36267626) (PMCID:PMC9577487)


Wainwright, C. L. et al. (2022) Future directions for the discovery of natural product-derived immunomodulating drugs. Pharmacological Research, 177, 106076. (doi: 10.1016/j.phrs.2022.106076) (PMID:35074524)

Wang, Y., Çil, Ç., Harnett, M. M. and Pineda, M. A. (2022) Cytohesin-2/ARNO: a novel bridge between cell migration and immunoregulation in synovial fibroblasts. Frontiers in Immunology, 12, 809896. (doi: 10.3389/fimmu.2021.809896) (PMID:35095899) (PMCID:PMC8790574)

Wang, Y., Pan, P., Khan, A., Çil, Ç. and Pineda, M. A. (2022) Synovial fibroblast sialylation regulates cell migration and activation of inflammatory pathways in arthritogenesis. Frontiers in Immunology, 13, 847581. (doi: 10.3389/fimmu.2022.847581) (PMID:35371069) (PMCID:PMC8971784)

Webster, H. C., Gamino, V., Andrusaite, A. T., Ridgewell, O., McCowan, J., Shergold, A. L., Heieis, G. A., Milling, S. W.F. , Maizels, R. M. and Perona-Wright, G. (2022) Tissue-based IL-10 signalling in helminth infection limits IFNγ expression and promotes the intestinal Th2 response. Mucosal Immunology, 15(6), pp. 1257-1269. (doi: 10.1038/s41385-022-00513-y) (PMID:35428872) (PMCID:PMC9705258)

Wiejak, J., Luchowska-Stańska, U., Wang, P., Zhou, J., Maffia, P. , Morgan, D., Barker, G. and Yarwood, S. J. (2022) Protein interaction, cytotoxic, transcriptomic and proteomic responses to structurally distinct EPAC1 activators in HUVECs. Scientific Reports, 12, 16505. (doi: 10.1038/s41598-022-20607-8) (PMID:36198739) (PMCID:PMC9534843)

Wilder-Smith, A. et al. (2022) The legacy of ZikaPLAN: a transnational research consortium addressing Zika. Global Health Action, 14(sup1), 2008139. (doi: 10.1080/16549716.2021.2008139) (PMID:35377284) (PMCID:PMC8986226)

Williams, J. A., Huesa, C., Windmill, J. F. C., Purcell, M., Reid, S., Coupaud, S. and Riddell, J. S. (2022) Spatiotemporal responses of trabecular and cortical bone to complete spinal cord injury in skeletally mature rats. Bone Reports, 16, 101592. (doi: 10.1016/j.bonr.2022.101592) (PMID:35637974) (PMCID:PMC9142855)

Willmore, E. G., Millar, N. L. and van der Windt, D. (2022) Post-surgical physiotherapy in frozen shoulder: a review. Shoulder and Elbow, 14(4), pp. 438-451. (doi: 10.1177/1758573220965870) (PMID:35846406) (PMCID:PMC9284307)

Wilson, G. J. , Fukuoka, A. , Vidler, F. and Graham, G. J. (2022) Diverse myeloid cells are recruited to the developing and inflamed mammary gland. Immunology, 165(2), pp. 206-218. (doi: 10.1111/imm.13430) (PMID:34775606)


Yogev, N. et al. (2022) CD4+ T-cell-derived IL-10 promotes CNS inflammation in mice by sustaining effector T cell survival. Cell Reports, 38(13), 110565. (doi: 10.1016/j.celrep.2022.110565) (PMID:35354043)

Yu, T., Schuette, F., Christofi, M., Forrester, J. V., Graham, G. J. and Kuffova, L. (2022) The atypical chemokine receptor-2 fine-tunes the immune response in herpes stromal keratitis. Frontiers in Immunology, 13, 1054260. (doi: 10.3389/fimmu.2022.1054260) (PMID:36518752) (PMCID:PMC9742518)

This list was generated on Mon May 29 09:54:19 2023 BST.